Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
- PMID: 26536114
- DOI: 10.1038/nature16057
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Abstract
Staphylococcus aureus is considered to be an extracellular pathogen. However, survival of S. aureus within host cells may provide a reservoir relatively protected from antibiotics, thus enabling long-term colonization of the host and explaining clinical failures and relapses after antibiotic therapy. Here we confirm that intracellular reservoirs of S. aureus in mice comprise a virulent subset of bacteria that can establish infection even in the presence of vancomycin, and we introduce a novel therapeutic that effectively kills intracellular S. aureus. This antibody-antibiotic conjugate consists of an anti-S. aureus antibody conjugated to a highly efficacious antibiotic that is activated only after it is released in the proteolytic environment of the phagolysosome. The antibody-antibiotic conjugate is superior to vancomycin for treatment of bacteraemia and provides direct evidence that intracellular S. aureus represents an important component of invasive infections.
Comment in
-
Antibiotics: Homed to the hideout.Nature. 2015 Nov 19;527(7578):309-10. doi: 10.1038/nature15647. Epub 2015 Nov 4. Nature. 2015. PMID: 26536107 No abstract available.
-
Antibacterial drugs: Antibody-antibiotic conjugate tracks down hidden S. aureus.Nat Rev Drug Discov. 2016 Jan;15(1):18. doi: 10.1038/nrd.2015.24. Nat Rev Drug Discov. 2016. PMID: 26718281 No abstract available.
-
Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way.Cell Host Microbe. 2016 Nov 9;20(5):555-557. doi: 10.1016/j.chom.2016.10.018. Cell Host Microbe. 2016. PMID: 27832585
Similar articles
-
Antibacterial drugs: Antibody-antibiotic conjugate tracks down hidden S. aureus.Nat Rev Drug Discov. 2016 Jan;15(1):18. doi: 10.1038/nrd.2015.24. Nat Rev Drug Discov. 2016. PMID: 26718281 No abstract available.
-
Antibiotics: Homed to the hideout.Nature. 2015 Nov 19;527(7578):309-10. doi: 10.1038/nature15647. Epub 2015 Nov 4. Nature. 2015. PMID: 26536107 No abstract available.
-
Antibody-antibiotic conjugate _targeted therapy for orthopedic implant-associated intracellular S. aureus infections.J Adv Res. 2024 Nov;65:239-255. doi: 10.1016/j.jare.2023.12.001. Epub 2023 Dec 3. J Adv Res. 2024. PMID: 38048846 Free PMC article.
-
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.Pharmacotherapy. 2015 Apr;35(4):424-32. doi: 10.1002/phar.1577. Pharmacotherapy. 2015. PMID: 25884530 Review.
-
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592. Clin Infect Dis. 2008. PMID: 18462091 Review.
Cited by
-
Catching Threads in Bacterial Cell Walls.ACS Cent Sci. 2022 Oct 26;8(10):1376-1379. doi: 10.1021/acscentsci.2c01070. Epub 2022 Oct 11. ACS Cent Sci. 2022. PMID: 36313163 Free PMC article. No abstract available.
-
Manipulation of host phagocytosis by fungal pathogens and therapeutic opportunities.Nat Microbiol. 2024 Sep;9(9):2216-2231. doi: 10.1038/s41564-024-01780-0. Epub 2024 Aug 26. Nat Microbiol. 2024. PMID: 39187614 Review.
-
The Microbiome, Antibiotics, and Health of the Pediatric Population.EC Microbiol. 2016 Mar;3(1):388-390. EC Microbiol. 2016. PMID: 27390782 Free PMC article. No abstract available.
-
Identification and treatment of the Staphylococcus aureus reservoir in vivo.J Exp Med. 2016 Jun 27;213(7):1141-51. doi: 10.1084/jem.20160334. Epub 2016 Jun 20. J Exp Med. 2016. PMID: 27325887 Free PMC article.
-
Resistance-resistant antibacterial treatment strategies.Front Antibiot. 2023;2:1093156. doi: 10.3389/frabi.2023.1093156. Epub 2023 Jan 30. Front Antibiot. 2023. PMID: 36845830 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases